GURU.Markets stock price, segment price, and overall market index valuation
The company's share price SOPHiA GENETICS SA
SOPHiA GENETICS is a genomic data analysis platform that helps hospitals and laboratories diagnose cancer and hereditary diseases. Its stock price reflects the growth of personalized medicine and the adoption of its cloud-based platform in clinical practice.
Share prices of companies in the market segment - It med
SOPHia GENETICS is a medical informatics company that provides a cloud-based platform for analyzing genomic and clinical data. We've categorized it as "Medical IT." The chart below shows how the market values companies at the intersection of healthcare and big data.
Broad Market Index - GURU.Markets
SOPHia GENETICS is a medical informatics company that provides a cloud-based platform for analyzing genomic and clinical data. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the healthcare IT sector.
Change in the price of a company, segment, and market as a whole per day
SOPH - Daily change in the company's share price SOPHiA GENETICS SA
For SOPHiA GENETICS, a genomic data analysis platform, change_co is a measure of volatility in the medical technology sector. Daily fluctuations reflect the pace of adoption of its platform by clinics. This metric is important for analyzing innovative healthcare companies on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - It med
SOPHiA GENETICS SA is a medical analytics company. This chart highlights the sector's high volatility. Comparing this to SOPH's AI-powered platform helps us understand how much its growth depends on the adoption of its technology in hospitals.
Daily change in the price of a broad market stock, index - GURU.Markets
SOPHiA is a company that provides a platform for analyzing genomic and clinical data. Its business operates at the intersection of IT and biotech. The chart below shows overall market volatility, which can be used to assess how the market perceives this business model.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization SOPHiA GENETICS SA
SOPHiA GENETICS SA's year-over-year performance reflects the adoption of its genomic data analysis platform in hospitals and laboratories. Its market capitalization growth over the past 12 months reflects the growing number of clients using its AI solutions to interpret complex genetic tests, making precision medicine more accessible.
Annual dynamics of market capitalization of the market segment - It med
SOPHiA GENETICS SA is a technology company providing an AI-powered platform for analyzing genomic and clinical data. Its solutions aid in diagnosis and treatment. The chart shows how its leadership in this fast-growing niche and subscription model enable it to outpace growth in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
SOPHiA GENETICS, with its medical data analytics platform, is a speculative bet on the future of medicine. Its stock price is unrelated to the economy, but driven by scientific breakthroughs and partnerships. The chart tells the story of investors' belief that AI will revolutionize diagnostics.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization SOPHiA GENETICS SA
The market capitalization of SOPHiA, a genomic data analysis platform, depends on R&D cycles. The monthly fluctuations on the chart reflect the growth in the number of tests performed through its platform by hospitals and laboratories that use AI to diagnose cancer and hereditary diseases.
Monthly dynamics of market capitalization of the market segment - It med
SOPHiA GENETICS provides an AI-powered platform for analyzing genomic and clinical data, helping hospitals make diagnoses. This sector of medical informatics lies at the intersection of healthcare and big data. The chart below reflects investors' belief in the potential of AI to revolutionize personalized medicine.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
SOPHiA GENETICS provides a platform for analyzing genomic data, helping hospitals make diagnoses. It is a technology company at the intersection of medicine and IT. Its stock price reflects the rapid adoption of big data in healthcare, a powerful long-term trend.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization SOPHiA GENETICS SA
Shares of SOPHiA GENETICS, a medical data analytics platform, reflect trends in personalized medicine. Weekly price movements depend on news of partnerships with clinics and laboratories, as well as the pace of implementation of their technology. The chart below shows how short-term developments in genomics and IT influence the company's valuation.
Weekly dynamics of market capitalization of the market segment - It med
Is SOPHiA GENETICS outperforming its peers in the medical IT sector? This chart compares the weekly stock performance of this genomic data analysis platform with the industry average. This allows us to assess whether its response to personalized medicine trends is stronger than that of its competitors, or whether it reflects general sentiment.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
SOPHiA GENETICS is an AI-powered genomic data analysis platform that aids in diagnostics. This chart compares its weekly performance to the market. It helps us understand whether it is perceived as a growth story, sensitive to overall sentiment in the tech sector, or a stable healthcare company.
Market capitalization of the company, segment and market as a whole
SOPH - Market capitalization of the company SOPHiA GENETICS SA
The SOPHiA GENETICS SA valuation chart is a bet on its genomic data analysis platform, which helps hospitals diagnose cancer and hereditary diseases. The company's market cap depends on the adoption of its software in clinics worldwide. The trend shows how investors view the future of data-driven medicine.
SOPH - Share of the company's market capitalization SOPHiA GENETICS SA within the market segment - It med
SOPHiA GENETICS SA is pursuing market share by providing an AI-powered platform for analyzing genomic and clinical data. Its market capitalization reflects its role in "democratizing" data-driven medicine for hospitals worldwide.
Market capitalization of the market segment - It med
The chart illustrates the total market capitalization of companies using AI to analyze genomic data. SOPHiA GENETICS is one of the leaders in this field. The graph shows how the market values platforms that help hospitals and laboratories make more accurate diagnoses.
Market capitalization of all companies included in a broad market index - GURU.Markets
This graph depicts the market value of smart medicine. SOPHiA GENETICS's market cap reflects the valuation of its AI-powered platform, which helps analyze genomic data for diagnostics. The line shows how big data and artificial intelligence are increasingly playing a significant role in the future of healthcare.
Book value capitalization of the company, segment and market as a whole
SOPH - Book value capitalization of the company SOPHiA GENETICS SA
SOPHiA GENETICS's core asset is its AI-powered cloud platform for genomic data analysis. The chart below reflects the financial valuation of this complex digital asset. The growth of the line reflects investments in software development, which helps hospitals and labs around the world interpret DNA tests.
SOPH - Share of the company's book capitalization SOPHiA GENETICS SA within the market segment - It med
For SOPHiA GENETICS, a data-driven medicine company, its tangible assets aren't factories, but powerful computing centers for genomic data analysis. The chart shows its share of this high-tech IT infrastructure, which is the physical core of its analytics platform.
Market segment balance sheet capitalization - It med
The chart shows the book value of the biotech sector. Against this backdrop, SOPHiA GENETICS, as a genomic data analysis platform, looks "light." Its value lies in AI and data, not labs. It provides the "brains," not capital-intensive sequencing equipment.
Book value of all companies included in the broad market index - GURU.Markets
SOPHiA GENETICS is not a laboratory, but an AI-powered platform for genomic data analysis. The company's assets are not sequencers, but cloud infrastructure and algorithms. The company's balance sheet is the value of the "collective intelligence" that helps hospitals around the world interpret complex genetic tests.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - SOPHiA GENETICS SA
SOPHiA GENETICS's balance sheet is its IT platform. Its market capitalization is a bet on its genomic data analysis platform becoming the standard for hospitals. The MvsBCap_Co chart shows how investors value its "network effect" relative to the value of its code and servers.
Market to book capitalization ratio in a market segment - It med
SOPHiA GENETICS is a company that provides a platform for analyzing genomic and clinical data, helping hospitals make diagnoses. Its value lies in AI and data. The chart shows the market premium placed on its technology platform and the network effect created by its global client network.
Market to book capitalization ratio for the market as a whole
SOPHiA GENETICS is a medical informatics company that provides an AI-powered platform for analyzing genomic data, helping hospitals and laboratories with diagnostics. The company's value lies in its technology and data. This chart illustrates why companies at the intersection of AI and medicine can command very high valuations.
Debts of the company, segment and market as a whole
SOPH - Company debts SOPHiA GENETICS SA
SOPHiA GENETICS, a medical informatics company, is using debt to develop its AI platform. This chart shows how the company is investing in technologies that help hospitals and labs analyze genomic data for diagnostics. The debt here represents an investment in creating a global standard for data analysis in medicine.
Market segment debts - It med
SOPHiA GENETICS is a company that provides an AI-powered platform that helps hospitals and laboratories analyze complex genomic and radiological data. This chart shows how the medical informatics company is funding the development of its sophisticated technology platform and expanding its global customer base.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio SOPHiA GENETICS SA
SOPHiA GENETICS provides a platform for analyzing medical data, helping clinics with diagnostics. This chart shows how the company finances its high-tech developments. In the field of medical informatics, debt can accelerate growth, but it also poses a risk if the company fails to expand its hospital client base quickly enough.
Market segment debt to market segment book capitalization - It med
SOPHiA GENETICS is a medical informatics company providing a platform for analyzing genomic data to aid in diagnosis and treatment. This is a rapidly growing sector. The chart shows how the company's leverage compares to the overall market capitalization of the medical technology industry.
Debt to book value of all companies in the market
SOPHiA GENETICS (SOPH) provides a cloud-based AI platform that helps clinics analyze genomic data for accurate diagnostics. This chart shows the overall debt-to-equity ratio in the market, reflecting global financial cycles. For a subscription-based SaaS business, it's interesting to assess how its conservative financial strategy compares to its overall debt load.
P/E of the company, segment and market as a whole
P/E - SOPHiA GENETICS SA
This metric for SOPHiA GENETICS, a company providing a genomic data analysis platform, is a measure of faith in personalized medicine. P/E is likely absent. The valuation is based on expectations that more hospitals and laboratories will use its platform to diagnose cancer and hereditary diseases.
P/E of the market segment - It med
This chart illustrates the average P/E for companies in the medical informatics sector. For SOPHiA GENETICS, with its genomic data analysis platform, this is an important benchmark. A P/E higher than the average would reflect investors' faith in its technological leadership and potential to become a standard in personalized medicine.
P/E of the market as a whole
SOPHiA GENETICS is a medical informatics company that provides a cloud-based AI platform for analyzing genomic and clinical data. The platform helps hospitals and laboratories diagnose cancer and hereditary diseases. This sentiment chart helps understand how investors view the digital health sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company SOPHiA GENETICS SA
SOPHiA GENETICS is a Swiss company that provides an AI-powered cloud platform that helps hospitals and laboratories analyze complex genomic and radiological data for diagnostic purposes. This graph reflects expectations for the future of precision medicine, based on the speed of adoption of its platform and the growing demand for data analysis in healthcare.
%20P%2FE%20SOPHiA%20GENETICS%20SA&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-SOPHiA-GENETICS-SA&v=1772616202658 "Chart of the company's future (projected) P/E SOPHiA GENETICS SA")
Future (projected) P/E of the market segment - It med
SOPHiA GENETICS provides a cloud-based AI platform for analyzing genomic and clinical data, helping hospitals and laboratories with diagnostics. This chart compares the company's future profitability expectations with industry forecasts. It reflects the market's belief that their platform will become the standard in data-driven medicine.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-It-med&v=1772616202781 "Future (projected) P/E graph of the market segment - It med")
Future (projected) P/E of the market as a whole
SOPHiA GENETICS is a company that has developed an AI-powered platform for analyzing genomic data, which aids in the diagnosis of cancer and hereditary diseases. This market expectations chart reflects investor willingness to invest in cutting-edge medical technologies. Market optimism facilitates raising capital for the development of such platforms.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772616202850 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit SOPHiA GENETICS SA
SOPHiA GENETICS is a medical informatics company. Its AI-powered cloud platform helps hospitals and laboratories analyze complex genomic data for cancer and hereditary disease diagnostics. Revenue depends on subscriptions to the platform and the growth of the genetic medicine market.
Profit of companies in the market segment - It med
SOPHiA GENETICS is a genomic data analysis platform that helps hospitals and laboratories make diagnoses. The company operates at the intersection of healthcare and IT. This graph illustrates how the digitalization of medicine and the use of big data are creating a new, rapidly growing sector that impacts the efficiency and future profitability of the entire healthcare system.
Overall market profit
SOPHiA GENETICS is a medical informatics company that provides a platform for analyzing genomic data. Its clients include hospitals and laboratories. The company's growth is fueled by the trend toward personalized medicine. This long-term shift provides demand that is less dependent on short-term economic cycles.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company SOPHiA GENETICS SA
SOPHiA GENETICS provides a cloud-based platform that uses artificial intelligence to analyze genomic and clinical data, helping hospitals make diagnoses. This chart reflects revenue expectations based on the adoption of its platform by medical institutions worldwide. The growth of personalized medicine is a key driver.
%20profit%20of%20the%20company%20SOPHiA%20GENETICS%20SA&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-SOPHiA-GENETICS-SA&v=1772616203095 "Graph of future (projected) profit of the company SOPHiA GENETICS SA")
Future (predicted) profit of companies in the market segment - It med
SOPHiA GENETICS provides a cloud platform for analyzing genomic and clinical data, helping hospitals make diagnoses. This chart shows the revenue forecast for the medical IT sector. It reflects expectations for the implementation of personalized medicine. This trend is the main driver for the expansion of the SOPHiA GENETICS platform.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-It-med&v=1772616203150 "Graph of future (predicted) profits of companies in a market segment - It med")
Future (predicted) profit of the market as a whole
SOPHiA GENETICS provides a platform for analyzing genomic data, helping hospitals and laboratories make diagnoses. Demand for its services is driven by the implementation of personalized medicine. Economic growth, as projected in the graph, is accelerating healthcare systems' investment in advanced diagnostic technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772616203173 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - SOPHiA GENETICS SA
SOPHiA GENETICS is a company that has developed a cloud-based AI platform for analyzing genomic and other medical data. It helps hospitals and laboratories make more accurate diagnoses. This chart shows how investors view its subscription-based revenue and its role in the emerging field of data-driven medicine.
P/S market segment - It med
SOPHiA GENETICS is a medical informatics company that has developed a cloud-based AI platform. The platform analyzes complex genomic data, helping hospitals and laboratories diagnose cancer and hereditary diseases. This chart shows the average rating in the sector, providing insight into how the market values this innovative platform.
P/S of the market as a whole
SOPHiA GENETICS is a medical informatics company that has developed a cloud-based AI platform for analyzing genomic and clinical data, helping hospitals make accurate diagnoses. This chart compares the high-end tech company's lofty revenue estimates with the more down-to-earth metrics of traditional companies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company SOPHiA GENETICS SA
SOPHiA GENETICS provides an AI-powered platform for genomic data analysis. Future revenue depends on its implementation in hospitals and laboratories for personalized medicine. This chart illustrates investor confidence in the growth of the genomics market and the company's role in it.
%20P%2FS%20SOPHiA%20GENETICS%20SA&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-SOPHiA-GENETICS-SA&v=1772616203260 "The graph of the company's future (projected) P/S SOPHiA GENETICS SA")
Future (projected) P/S of the market segment - It med
SOPHiA GENETICS is a medical informatics company that provides an AI-powered platform for analyzing genomic and clinical data. This chart compares the company's estimated future sales with other medical IT companies, showing how investors view its role in the development of precision medicine.
%20P%2FS%20market%20segment%20graph%20-%20It%20med&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-It-med&v=1772616203293 "Future (projected) P/S market segment graph - It med")
Future (projected) P/S of the market as a whole
SOPHiA GENETICS is a medical informatics company. Its platform helps hospitals analyze complex genomic data for diagnostic purposes. The market optimism, evident in this chart, is based on a belief in personalized medicine. SOPHiA provides the tools that make this future of medicine accessible today.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772616203311 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales SOPHiA GENETICS SA
SOPHiA GENETICS provides a cloud-based AI platform that helps hospitals and laboratories analyze complex genomic data for cancer and hereditary disease diagnostics. The company's revenue comes from fees paid for using its platform. The chart below shows the growing adoption of its technology in precision medicine worldwide.
Sales of companies in the market segment - It med
SOPHiA GENETICS is a cloud-based platform for analyzing genomic and clinical data. Its AI-powered technology helps hospitals and laboratories worldwide interpret complex data to diagnose cancer and rare diseases. This chart illustrates the growth of the personalized medicine market, where SOPHiA is a key player in data processing.
Overall market sales
SOPHiA GENETICS is a platform for analyzing genomic and clinical data, aiding in diagnosis and treatment. Demand for its services is driven by the growth of personalized medicine. This trend, reflecting economic health, impacts the budgets of hospitals and laboratories, the company's primary clients.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company SOPHiA GENETICS SA
SOPHiA GENETICS is a company that provides a cloud-based platform for genomic data analysis. Hospitals and laboratories use it to interpret genetic test results, aiding in the diagnosis of cancer and rare diseases. This chart shows analysts' expectations for the genetic testing market growth and the adoption of the platform in clinics.
%20sales%20of%20the%20company%20SOPHiA%20GENETICS%20SA&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-SOPHiA-GENETICS-SA&v=1772616203432 "Schedule of future (projected) sales of the company SOPHiA GENETICS SA")
Future (projected) sales of companies in the market segment - It med
SOPHiA GENETICS provides a cloud platform for analyzing genomic and clinical data, helping hospitals and laboratories with diagnostics. This chart illustrates expectations for the medical informatics sector. It helps analyze how the trend toward personalized medicine and the use of big data are driving demand for the company's intelligent platform.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-It-med&v=1772616203502 "Schedule of future (projected) sales of companies in the market segment - It med")
Future (projected) sales of the market as a whole
SOPHiA GENETICS SA provides an AI-powered platform for analyzing genomic and clinical data. This graph, reflecting investments in personalized medicine, is important to the company. Growth in this area encourages hospitals and laboratories to implement advanced analytical tools to improve diagnostics and treatment, driving demand for the SOPHiA platform.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772616203590 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality SOPHiA GENETICS SA
SOPHiA GENETICS provides a cloud platform that helps hospitals and laboratories analyze complex genomic data for the diagnosis and treatment of cancer and hereditary diseases. It operates at the intersection of healthcare and IT. This chart shows how the company is scaling its platform, striving to turn big data into a profitable business model.
Market segment marginality - It med
SOPHiA GENETICS is a company that has created a cloud-based platform for analyzing genomic and clinical data. It helps hospitals and laboratories worldwide diagnose cancer and hereditary diseases. This chart shows how profitable their data-as-a-service (DaaS) model is in the rapidly growing personalized medicine sector.
Market marginality as a whole
SOPHiA GENETICS is a company that provides a cloud-based platform for analyzing genomic and clinical data, helping hospitals and laboratories make diagnoses. In terms of overall profitability, their business is a bet on data-driven medicine. Their profitability depends on the adoption of their platform and the ability to monetize massive volumes of data.
Employees in the company, segment and market as a whole
Number of employees in the company SOPHiA GENETICS SA
SOPHiA GENETICS is a medical informatics company providing a platform for genomic data analysis. This graph shows the team of bioinformaticians and data scientists. The growth reflects the increasing adoption of genomics in clinical practice and hospitals' need for data interpretation tools.
Share of the company's employees SOPHiA GENETICS SA within the market segment - It med
SOPHiA GENETICS provides an AI-powered platform that helps hospitals and laboratories analyze complex genomic and clinical data. This chart shows its share of the medical informatics sector, reflecting its team of bioinformatics and machine learning specialists democratizing data-driven medicine.
Number of employees in the market segment - It med
SOPHiA GENETICS provides a cloud-based AI platform for genomic data analysis, helping hospitals and laboratories diagnose cancer and hereditary diseases. This chart shows the rapid growth of employment in the medical informatics sector. The increase in staff reflects the growing adoption of genomics in clinical practice and the need for sophisticated analytical tools.
Number of employees in the market as a whole
SOPHiA GENETICS SA is a Swiss company that has developed an AI-powered cloud platform that helps hospitals and laboratories analyze complex genomic data for the diagnosis of cancer and hereditary diseases. This graph shows the overall labor market, and companies like SOPHiA are at the intersection of healthcare and IT, creating demand for bioinformatics and machine learning specialists.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company SOPHiA GENETICS SA (SOPH)
SOPHiA GENETICS SA provides a platform for genomic data analysis powered by artificial intelligence. It's a knowledge-intensive IT business. This chart demonstrates a very high capitalization per employee. Their platform, created by a team of scientists and developers, enables clinics worldwide to analyze complex data, demonstrating high scalability and the value of intellectual capital.
%20of%20the%20company%20SOPHiA%20GENETICS%20SA%20(SOPH)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-SOPHiA-GENETICS-SA-SOPH&v=1772616203828 "Chart of market capitalization per employee (in thousands of dollars) of the company SOPHiA GENETICS SA (SOPH)")
Market capitalization per employee (in thousands of dollars) in the market segment - It med
SOPHiA GENETICS provides an AI-powered platform for analyzing genomic and clinical data, helping hospitals make diagnoses. It's an example of data-driven medicine. The chart shows how the market values its technology platform. The high cost per employee reflects the potential of its SaaS model for global scalability.
%20by%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-It-med&v=1772616203880 "Market capitalization per employee (in thousands of dollars) by market segment - It med")
Market capitalization per employee (in thousands of dollars) for the overall market
SOPHiA GENETICS provides a cloud-based AI platform for genomic data analysis, helping hospitals and labs diagnose cancer and hereditary diseases. This chart shows a high market price per employee, reflecting the value of their sophisticated analytics platform for the future of personalized medicine.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772616203907 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company SOPHiA GENETICS SA (SOPH)
SOPHiA GENETICS (SOPH) is a SaaS platform company for analyzing genomic and medical data. They help hospitals and labs interpret complex tests. This chart shows how effectively they monetize their data platform. It measures how much revenue each employee (scientist, engineer) generates.
%20Chart%20SOPHiA%20GENETICS%20SA%20(SOPH)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-SOPHiA-GENETICS-SA-SOPH&v=1772616203913 "Company Profit Per Employee (in thousands of dollars) Chart SOPHiA GENETICS SA (SOPH)")
Profit per employee (in thousands of dollars) in the market segment - It med
SOPHiA GENETICS provides a data analytics platform for precision medicine. They help hospitals analyze genomic data for cancer diagnostics. This chart shows the industry benchmark. It helps evaluate how effectively the SOPHiA team (bioinformaticians and developers) is monetizing their sophisticated analytics platform.
%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-It-med&v=1772616203922 "Chart of profit per employee (in thousands of dollars) in the market segment - It med")
Profit per employee (in thousands of dollars) for the market as a whole
SOPHiA GENETICS is a SaaS platform for analyzing genomic and radiological data. Hospitals and labs use their software (and AI) to interpret complex tests (for example, for cancer). It's a high-tech B2B business. This graph shows how scalable their platform is: whether they can add new hospitals without increasing their bioinformatics staff proportionally.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772616203971 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee SOPHiA GENETICS SA (SOPH)
SOPHiA GENETICS provides a cloud platform for analyzing genomic and clinical data, helping hospitals with diagnostics. This chart demonstrates the effectiveness of the SaaS model in healthcare. The increase in revenue per employee reflects the increase in the number of partner clinics and the volume of data analyzed on their platform.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-SOPHiA-GENETICS-SA-SOPH&v=1772616203990 "Sales chart per company employee SOPHiA GENETICS SA (SOPH)")
Sales per employee in the market segment - It med
SOPHiA GENETICS (SOPH) is a Swiss healthtech company. They provide an AI-powered SaaS platform that helps hospitals and labs analyze complex genomic data. This graph shows the revenue (from subscriptions) generated by each employee (scientist, programmer). This is an indicator of the scalability of their data-driven platform.
Sales per employee for the market as a whole
SOPHiA GENETICS (SOPH) is a healthcare technology company. They have created a cloud-based AI platform that helps hospitals analyze complex genomic data. It's a SaaS platform. This chart shows how successfully their team of engineers and bioinformaticians generates recurring revenue (via subscription) from data analysis for the medical community.
Short shares by company, segment and market as a whole
Shares shorted by company SOPHiA GENETICS SA (SOPH)
SOPHiA GENETICS is a company that provides an AI-powered platform for analyzing genomic and clinical data, helping hospitals with diagnostics. This chart shows bearish bets. The shorts may be due to concerns about the speed of commercialization of their platform or the high level of competition in the medical analytics field.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-SOPHiA-GENETICS-SA-SOPH&v=1772616204046 "Short Shares Chart for the Company SOPHiA GENETICS SA (SOPH)")
Shares shorted by market segment - It med
SOPHiA GENETICS (SOPH) is a technology company that provides an AI-powered platform for analyzing genomic and medical data, helping hospitals with diagnostics. This chart shows the odds against the IT healthcare sector. The rising odds against the industry reflect concerns that hospitals and labs will cut spending on expensive IT platforms due to the recession.
Shares shorted by the overall market
SOPHiA GENETICS provides a platform for analyzing genomic data in medicine. This is an innovative, rapidly growing field. However, when fear mounts in the market (as in this chart), investors often sell off high-growth tech stocks that have yet to achieve profitability. SOPHiA, despite its potential, is caught in this wave of risk-off.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator SOPHiA GENETICS SA (SOPH)
SOPHiA GENETICS provides a platform for analyzing genomic data in oncology. Business depends on R&D budgets and clinical implementation. A chart above 70 may reflect strong growth or optimism for the sector. A range below 30 is associated with a "venture winter" or slow platform adoption.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-SOPHiA-GENETICS-SA-SOPH&v=1772616204056 "RSI 14 indicator chart for the company's stock SOPHiA GENETICS SA (SOPH)")
RSI 14 Market Segment - It med
SOPHiA GENETICS is a data-driven medicine company. Its AI-powered SaaS platform helps hospitals analyze genomic data for cancer and rare disease diagnostics. This graph measures the overall momentum of the entire healthcare IT solutions sector. It helps assess whether SOPH is a unique player or simply part of the general tide of technological overheating in healthcare.
RSI 14 for the overall market
SOPHiA GENETICS (SOPH), a genomic analytics platform. This chart is an indicator of R&D budgets. In the euphoria of biotech, labs and laboratories (its clients) are generously funded and buying new software. In times of panic and recession, R&D budgets are cut, and the purchase of expensive "innovative" platforms is postponed.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SOPH (SOPHiA GENETICS SA)
SOPHiA GENETICS is a Swiss data-driven medicine company. Its cloud-based SaaS platform (SOPHiA DDM) helps hospitals and labs analyze complex genomic and radiological data. This chart shows the average target price from analysts estimating the platform's user growth.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-SOPH-SOPHiA-GENETICS-SA&v=1772616204116 "A chart showing analyst consensus forecasts for the expected stock price. SOPH (SOPHiA GENETICS SA)")
The difference between the consensus estimate and the actual stock price SOPH (SOPHiA GENETICS SA)
SOPHiA GENETICS (SOPH) is a healthcare SaaS company. It provides a global AI platform that helps hospitals analyze complex genetic data (genomics, oncology). This chart shows the difference between the consensus forecast and the price. It reflects analysts' confidence in this B2B SaaS model and its potential to become a standard.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-SOPH-SOPHiA-GENETICS-SA&v=1772616204118 "A chart showing the difference between the consensus forecast and the actual stock price. SOPH (SOPHiA GENETICS SA)")
Analyst consensus forecast for stock prices by market segment - It med
SOPHiA GENETICS is a "Google translator" for genomes. The Swiss company provides a SaaS platform that helps hospitals analyze complex genetic data (DNA) for cancer and rare disease diagnostics. This chart shows the general expectations of analysts in the healthcare IT sector, reflecting whether experts believe in the rise of "data-driven medicine."
Analysts' consensus forecast for the overall market share price
SOPHiA is an "AI platform" for "genomics." They "help" "hospitals" "analyze" "DNA data" (for "oncology"). This chart of overall market sentiment is important. "Optimism" = "hospitals" "spend" on "new" "technologies." "Pessimism" = "investors" "flee" "loss-making" "AI companies" (like SOPH) that "require" R&D "funding."
AKIMA index of the company, segment and market as a whole
AKiMA Company Index SOPHiA GENETICS SA
SOPHiA GENETICS (SOPH) is a Swiss healthcare data company. They don't produce tests, but rather provide an AI-powered SaaS platform that helps hospitals and labs analyze complex genomic data (NGS). This graph is a genomics pick and shovel. It measures their ability to penetrate labs and scale up the number of tests processed through their platform.
AKIMA Market Segment Index - It med
SOPHiA GENETICS is a Swiss company that provides an AI-powered platform for analyzing genomic and clinical data, helping hospitals with diagnostics. This chart shows the average index for the medical informatics sector. It allows one to assess how SOPHiA's high-tech platform performs compared to the industry average.
The AKIM Index for the overall market
SOPHiA GENETICS is a healthcare company using AI to analyze complex genomic and clinical data (data-driven medicine). This chart, which reflects the market average, provides context. It helps assess how this technology platform for hospitals and laboratories compares to overall macroeconomic trends and the digitalization of medicine.
